20-Mar-2026
Medicare Advantage payments in focus as regulator says insurers yet to rein in costs
Seeking Alpha News (Fri, 20-Mar 2:04 PM ET)
Wave of Insider Stock Sales Sweeps Through Alignment Healthcare’s Top Ranks
TipRanks (Thu, 19-Mar 10:02 PM ET)
ALHC’s 13.17 Million Share Secondary Offering Priced at $19.46—Here’s What Investors Should Know
Market Chameleon (Tue, 3-Mar 3:36 AM ET)
Alignment Healthcare Announces Pricing of Secondary Offering
Globe Newswire (Mon, 2-Mar 9:05 PM ET)
Alignment Healthcare Announces Secondary Offering
Globe Newswire (Mon, 2-Mar 4:47 PM ET)
Alignment Healthcare Delivers 46% Revenue Growth in 2025—Raises Guidance and Achieves Free Cash Flow
Market Chameleon (Fri, 27-Feb 4:48 AM ET)
Globe Newswire (Thu, 26-Feb 4:01 PM ET)
Alignment Healthcare to Present at the Leerink Partners Global Healthcare Conference
Globe Newswire (Mon, 23-Feb 8:00 AM ET)
Globe Newswire (Thu, 5-Feb 8:00 AM ET)
Alignment Healthcare Named to the 2026 Fortune World's Most Admired Companies List for First Time
Globe Newswire (Wed, 21-Jan 11:00 AM ET)
Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes.
Alignment Healthcare trades on the NASDAQ stock market under the symbol ALHC.
As of March 20, 2026, ALHC stock price declined to $17.34 with 4,244,051 million shares trading.
ALHC has a beta of 0.27, meaning it tends to be less sensitive to market movements. ALHC has a correlation of 0.01 to the broad based SPY ETF.
ALHC has a market cap of $3.47 billion. This is considered a Mid Cap stock.
Last quarter Alignment Healthcare reported $1 billion in Revenue and -$.05 earnings per share. This beat revenue expectation by $11 million and exceeded earnings estimates by $.06.
In the last 3 years, ALHC traded as high as $23.87 and as low as $4.46.
The top ETF exchange traded funds that ALHC belongs to (by Net Assets): VTI, IWM, VB, VBK, VXF.
ALHC has underperformed the market in the last year with a price return of +0.9% while the SPY ETF gained +16.6%. ALHC has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -15.1% and -6.0%, respectively, while the SPY returned -4.4% and -3.3%, respectively.
ALHC support price is $17.59 and resistance is $18.73 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ALHC shares will trade within this expected range on the day.